CoChat

Large-Scale Production and Structural and Biophysical Characterizations of the Human Hepatitis B Virus Polymerase

Open access

The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.

Abstract

Hepatitis B virus (HBV) is a major human pathogen that causes serious liver disease and 600,000 deaths annually. Approved therapies for treating chronic HBV infections usually target the multifunctional viral polymerase (hPOL). Unfortunately, these therapies—broad-spectrum antivirals—are not general cures, have side effects, and cause viral resistance. While hPOL remains an attractive therapeutic target, it is notoriously difficult to express and purify in a soluble form at yields appropriate for structural studies. Thus, no empirical structural data exist for hPOL, and this impedes medicinal chemistry and rational lead discovery efforts targeting HBV. Here, we present an efficient strategy to overexpress recombinant hPOL domains in Escherichia coli , purifying them at high yield and solving their known aggregation tendencies. This allowed us to perform the first structural and biophysical characterizations of hPOL domains. Apo-hPOL domains adopt mainly α-helical structures with small amounts of β-sheet structures. Our recombinant material exhibited metal-dependent, reverse transcriptase activity in vitro , with metal binding modulating the hPOL structure. Calcomine orange 2RS, a small molecule that inhibits duck HBV POL activity, also inhibited the in vitro priming activity of recombinant hPOL. Our work paves the way for structural and biophysical characterizations of hPOL and should facilitate high-throughput lead discovery for HBV. IMPORTANCE The viral polymerase from human hepatitis B virus (hPOL) is a well-validated therapeutic target. However, recombinant hPOL has a well-deserved reputation for being extremely difficult to express in a soluble, active form in yields appropriate to the structural studies that usually play an important role in drug discovery programs. This has hindered the development of much-needed new antivirals for HBV. However, we have solved this problem and report here procedures for expressing recombinant hPOL domains in Escherichia coli and also methods for purifying them in soluble forms that have activity in vitro . We also present the first structural and biophysical characterizations of hPOL. Our work paves the way for new insights into hPOL structure and function, which should assist the discovery of novel antivirals for HBV.

Overview

Integrity signals

Registry

Crossref · 10.1128/jvi.02575-13

Cites

89 of 89 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 2

  1. TheisenA. 2000. Refractive increment data book for polymer and biomolecular scientists. Nottingham University Press, Nottingham, United Kingdom.
  2. 10.01089/adt.2011.0380 · doi:10.01089/adt.2011.0380

Cited by

See all 27

Metadata

Authors
Vörös, J., Urbanek, A., Rautureau, G. J. P., O'Connor, M., Fisher, H. C., Ashcroft, A. E., & Ferguson, N.
Affiliations
  • University College Dublin (IE)
  • University of Leeds (GB)
Venue
Journal of Virology
Published
2014-03
Volume
88
Issue
5
Pages
2584-2599
ISSN
  • 0022-538X (ISSN-L)
  • 1098-5514
OpenAlex
W2085965763
Cited by
27
References
89
Citations by year
2024: 2 · 2023: 2 · 2022: 2 · 2020: 6 · 2019: 4 · 2018: 1 · 2016: 3 · 2015: 3 · 2014: 4
FWCI
1.50
Type
journal article
Language
en
Open access
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Journal of Virology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
  • Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
Keywords
hepatitis B virus, viral polymerase, recombinant protein expression, protein purification, protein aggregation, protein structure, reverse transcriptase activity, metal ion binding, calmodulin, calmodulin antagonists, antiviral drug discovery, therapeutic target
MeSH terms
Algorithms, Circular Dichroism, Hepatitis B virus, Humans, Models, Molecular, Protein Binding, Recombinant Proteins, Ribonucleoproteins, Mass Spectrometry, Gene Products, pol, Protein Structure, Secondary, Protein Interaction Domains and Motifs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.